Literature DB >> 27639089

Adenovirus sensing by the immune system.

Svetlana Atasheva1, Dmitry M Shayakhmetov2.   

Abstract

The host immune system developed multiple ways for recognition of viral pathogens. Upon disseminated adenovirus infection, the immune system senses adenovirus invasion from the moment it enters the bloodstream. The soluble blood factors, FX, antibodies, and complement, can bind and activate plethora of host-protective immune responses. Adenovirus binding to the cellular β3 integrin and endosomal membrane rupture trigger activation of IL-1α/IL-1R1 proinflammatory cascade leading to attraction of cytotoxic immune cells to the site of infection. Upon cell entry, adenovirus exposes its DNA genome in the cytoplasm and triggers DNA sensors signaling. Even when inside the nucleus, the specialized cellular machinery that recognizes the double-strand DNA breaks become activated and triggers viral DNA replication arrest. Thus, the host employs very diverse mechanisms to prevent viral dissemination. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27639089      PMCID: PMC5138075          DOI: 10.1016/j.coviro.2016.08.017

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  33 in total

1.  Adenovirus type 5 rupture of lysosomes leads to cathepsin B-dependent mitochondrial stress and production of reactive oxygen species.

Authors:  Kathleen A McGuire; Arlene U Barlan; Tina M Griffin; Christopher M Wiethoff
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  Viral and Cellular Genomes Activate Distinct DNA Damage Responses.

Authors:  Govind A Shah; Clodagh C O'Shea
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

3.  Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways.

Authors:  Jiangao Zhu; Xiaopei Huang; Yiping Yang
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

4.  Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator.

Authors:  Marcelo Nociari; Oksana Ocheretina; John W Schoggins; Erik Falck-Pedersen
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

Review 5.  Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.

Authors:  Richard E Randall; Stephen Goodbourn
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

6.  Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo.

Authors:  Daniel M Appledorn; Sonika Patial; Aaron McBride; Sarah Godbehere; Nico Van Rooijen; Narayanan Parameswaran; Andrea Amalfitano
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

7.  Unexpected pulmonary uptake of adenovirus vectors in animals with chronic liver disease.

Authors:  J S Smith; J Tian; J Muller; A P Byrnes
Journal:  Gene Ther       Date:  2004-03       Impact factor: 5.250

Review 8.  Intracellular NOD-like receptors in innate immunity, infection and disease.

Authors:  Luigi Franchi; Jong-Hwan Park; Michael H Shaw; Noemi Marina-Garcia; Grace Chen; Yun-Gi Kim; Gabriel Núñez
Journal:  Cell Microbiol       Date:  2007-10-18       Impact factor: 3.715

9.  Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.

Authors:  Daniela Anghelina; Eric Lam; Erik Falck-Pedersen
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

10.  IL-1α and complement cooperate in triggering local neutrophilic inflammation in response to adenovirus and eliminating virus-containing cells.

Authors:  Nelson C Di Paolo; Lisa K Baldwin; Eric E Irons; Thalia Papayannopoulou; Stephen Tomlinson; Dmitry M Shayakhmetov
Journal:  PLoS Pathog       Date:  2014-03-20       Impact factor: 6.823

View more
  15 in total

Review 1.  In Vivo Hematopoietic Stem Cell Transduction.

Authors:  Maximilian Richter; Daniel Stone; Carol Miao; Olivier Humbert; Hans-Peter Kiem; Thalia Papayannopoulou; André Lieber
Journal:  Hematol Oncol Clin North Am       Date:  2017-10       Impact factor: 3.722

2.  Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9.

Authors:  Calvin J Stephens; Elvin J Lauron; Elena Kashentseva; Zhi Hong Lu; Wayne M Yokoyama; David T Curiel
Journal:  J Control Release       Date:  2019-02-13       Impact factor: 9.776

3.  Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing.

Authors:  Chang Li; Nikoletta Psatha; Pavel Sova; Sucheol Gil; Hongjie Wang; Jiho Kim; Chandana Kulkarni; Cristina Valensisi; R David Hawkins; George Stamatoyannopoulos; André Lieber
Journal:  Blood       Date:  2018-05-22       Impact factor: 22.113

4.  E1B-55K Is a Phosphorylation-Dependent Transcriptional and Posttranscriptional Regulator of Viral Gene Expression in Human Adenovirus C5 Infection.

Authors:  Paloma Hidalgo; Yasel Garcés; Eduardo Mundo; Raúl E López; Luca D Bertzbach; Thomas Dobner; Ramón A González
Journal:  J Virol       Date:  2022-01-12       Impact factor: 6.549

Review 5.  Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines.

Authors:  Lynda Coughlan
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

Review 6.  Development of New Strategies Using Extracellular Vesicles Loaded with Exogenous Nucleic Acid.

Authors:  Nicola Salvatore Orefice
Journal:  Pharmaceutics       Date:  2020-07-26       Impact factor: 6.321

7.  Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site.

Authors:  Alessandra Lopes; Sara Feola; Sophie Ligot; Manlio Fusciello; Gaëlle Vandermeulen; Véronique Préat; Vincenzo Cerullo
Journal:  J Immunother Cancer       Date:  2019-07-10       Impact factor: 13.751

Review 8.  Pathogenesis of Hypervirulent Fowl Adenovirus Serotype 4: The Contributions of Viral and Host Factors.

Authors:  Zeng Wang; Jun Zhao
Journal:  Viruses       Date:  2019-08-12       Impact factor: 5.048

Review 9.  Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer.

Authors:  Rebeca Gonzalez-Pastor; Peter S Goedegebuure; David T Curiel
Journal:  Cancer Gene Ther       Date:  2020-09-19       Impact factor: 5.987

10.  Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9.

Authors:  Calvin J Stephens; Elena Kashentseva; William Everett; Lyudmila Kaliberova; David T Curiel
Journal:  Gene Ther       Date:  2018-03-27       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.